The effect of chronic toxicity of pethidine on the spinal cord: An experimental model in rabbits

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 3, 2013, Pages 617-622

  Pestean C ^a   Taulescu, M ^a   Ober, C ^a   Catoi C ^a   MiclauS V ^a   Oana, L ^a   Bodolea, C ^b  

^a UNIVERSITY OF AGRICULTURAL SCIENCES AND VETERINARY MEDICINE   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Epidural; Neurotoxicity; Pethidine; Rabbit; Spinal cord

Indexed keywords

CENTRAL DEPRESSANT AGENT; PETHIDINE;

ANIMAL; ARTICLE; DISEASE MODEL; DRUG EFFECT; HUMAN; MALE; PATHOLOGY; RABBIT; RANDOMIZATION; SPINAL CORD; TREATMENT OUTCOME;

ADJUVANTS, ANESTHESIA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MEPERIDINE; RABBITS; RANDOM ALLOCATION; SPINAL CORD; TREATMENT OUTCOME;

EID: 84884568885     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Hodgson PS, Neal JM, Pollock JE, Liu SS, The neurotoxicity of drugs given intrathecally (spinal), Anesth Analg, 1999, 88(4):797-809.
2. Morgan M, The rational use of intrathecal and extradural opioids, Br J Anaesth, 1989, 63(2):165-188.
3. Bernards CM, The spinal meninges and their role in spinal drug movement. In: Yaksh TL (ed), Spinal drug delivery, Elsevier, Amsterdam, 1999, 133-143.
4. Woodhouse A, Ward ME, Mather LE, Intra-subject variability in post-operative patient-controlled analgesia (PCA): is the patient equally satisfied with morphine, pethidine and fentanyl? Pain, 1999, 80(3):545-553.
5. Acalovschi I, Bodolea C, Manoiu C, Spinal anesthesia with meperidine. Effects of added alpha-adrenergic agonists: epinephrine versus clonidine, Anesth Analg, 1997, 84(6): 1333-1339.
6. Harvey SC, O'Neil MG, Pope CA, Cuddy BG, Duc TA, Continuous intrathecal meperidine via an implantable infusion pump for chronic, nonmalignant pain, Ann Pharmacother, 1997, 31(11):1306-1308.
7. Souter KJ, Davies JM, Loeser JD, Fitzgibbon DR, Continuous intrathecal meperidine for severe refractory cancer pain: a case report, Clin J Pain, 2005, 21(2):193-196.
8. Wagemans MF, Zuurmond WW, de Lange JJ, Long-term spinal opioid therapy in terminally Ill cancer pain patients, Oncologist, 1997, 2(2):70-75.
9. Artru A, Spinal cerebrospinal chemistry and physiology. In: Yaksh TL (ed), Spinal drug delivery, Elsevier, Amsterdam, 1999, 177-193.
10. Latta KS, Ginsberg B, Barkin RL, Meperidine: a critical review, Am J Ther, 2002, 9(1):53-68.
11. Malinovsky JM, Pinaud M, Neurotoxicity of intrathecally administrated agents, Ann Fr Anesth Reanim, 1996, 15(5): 647-658.
12. Hagmeyer KO, Mauro LS, Mauro VF, Meperidine-related seizures associated with patient-controlled analgesia pumps, Ann Pharmacother, 1993, 27(1):29-32.
13. Pöpping DM, Elia N, Marret E, Wenk M, Tramèr MR, Opioids added to local anesthetics for single-shot intrathecal anesthesia in patients undergoing minor surgery: a meta-analysis of randomized trials, Pain, 2012, 153(4):784-793.
14. Paech MJ, Unexplained neurologic deficit after uneventful combined spinal and epidural anesthesia for cesarean delivery, Reg Anesth, 1997, 22(5):479-482.
15. Grace D, Fee JPH, Anaesthesia and adverse effects after intrathecal pethidine hydrochloride for urological surgery, Anaesthesia, 1995, 50(12):1036-1040.
16. Nylander WA Jr, Plunkett RJ, Hammon JW Jr, Oldfield EH, Meacham WF, Thiopental modification of ischemic spinal cord injury in the dog, Ann Thorac Surg, 1982, 33(1):64-68.
17. Vranken JH, Troost D, de Haan P, Pennings FA, van der Vegt MH, Dijkgraaf MG, Hollmann MW, Severe toxic damage to the rabbit spinal cord after intrathecal administration of preservative-free S(+)-ketamine, Anesthesiology, 2006, 105(4): 813-818.
18. Jaffe RA, Rowe MA, A comparison of the local anesthetic effects of meperidine, fentanyl, and sufentanil on dorsal root axons, Anesth Analg, 1996, 83(4):776-781.
19. Gissen AJ, Gugino LD, Datta S, Miller J, Covino BG, Effects of fentanyl and sufentanil on peripheral mammalian nerves, Anesth Analg, 1987, 66(12):1272-1276.
20. Hindle A, Intrathecal opioids in the management of acute postoperative pain, Contin Educ Anaesth Crit Care Pain, 2008, 8(3):81-85.
21. Ibusuki S, Choi JH, Fang Z, Bollen A, Drasner K, Comparative neurotoxicity of intrathecal meperidine and lidocaine in the rat, Anesthesiology, 2000, 93(3A):725.
22. Yaksh TL, Noueihed RY, Durant PAC, Studies of the pharmacology and pathology of intrathecally administered 4-anilinopiperidine analogues and morphine in the rat and cat, Anesthesiology, 1986, 64(1):54-66.
23. Sabbe MB, Grafe MR, Mjanger E, Tiseo PJ, Hill HF, Yaksh TL, Spinal delivery of sufentanil, alfentanil, and morphine in dogs. Physiologic and toxicologic investigations, Anesthesiology, 1994, 81(4):899-920.
24. Fukushima S, Takenami T, Yagishita S, Nara Y, Hoka S, Okamoto H, Neurotoxicity of intrathecally administered fentanyl in a rat spinal model, Pain Med, 2011, 12(5):717-725.
25. Rawal N, Nuutinen L, Raj PP, Lovering SL, Gobuty AH, Hargardine J, Lehmkuhl L, Herva R, Abouleish E, Behavioral and histopathologic effects following intrathecal administration of butorphanol, sufentanil, and nalbuphine in sheep, Anesthesiology, 1991, 75(6):1025-1034.
26. Allen JW, Horais KA, Tozier NA, Yaksh TL, Opiate pharmacology of intrathecal granulomas, Anesthesiology, 2006, 105(3):590-598.
27. Gradert TL, Baze WB, Satterfield WC, Hildebrand KR, Johansen MJ, Hassenbusch SJ, Safety of chronic intrathecal morphine infusion in a sheep model, Anesthesiology, 2003, 99(1):188-198.
28. Deer T, Krames ES, Hassenbusch S, Burton A, Caraway D, Dupen S, Eisenach J, Erdek M, Grigsby E, Kim P, Levy R, McDowell G, Mekhail N, Panchal S, Prager J, Rauck R, Saulino M, Sitzman T, Staats P, Stanton-Hicks M, Stearns L, Dean Willis K, Witt W, Follett K, Huntoon M, Liem L, Rathmell J, Wallace M, Buchser E, Cousins M, Ver Donck A, Management of intrathecal catheter-tip inflammatory masses: an updated 2007 Consensus Statement from an Expert Panel, Neuromodulation, 2008, 11(2):77-91.
29. Canduz B, Aktug H, Mavioǧlu O, Erkin Y, Yilmaz O, Uyanikgil Y, Korkmaz H, Baka M, Epidural lornoxicam administration - innocent, J Clin Neurosci, 2007, 14(10):968-974.
30. Shipton E, Should New Zealand continue signing up to the Pethidine Protocol? N Z Med J, 2006, 119(1230):U1875.
31. rd edition, Lippincott Williams & Wilkins, Baltimore, 2001, 1682-1709.